KYMR - Balance Sheet - Kymera Therapeutics, Inc.

Current Liabilities	67.8 M
Accounts Payable	5.99 M
Short-Term Debt	13.1 M
Other Current Liabilities	48.7 M
Non-Current Liabilities	74.6 M
Long-Term Debt	0
Other Non-Current Liabilities	74.6 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	120.3	110.0	68.4	48.0	31.0	76.0	41.3
Short Term Investments	368.5	264.9	338.8	394.4	265.2	15.9	0
Receivables	0.9	18.8	2.5	0.1	1.4	0	0.1
Inventory	0	0	(12.2)	(9.0)	(163.4)	0	0
Other Current Assets	20.6	11.7	9.7	8.7	4.7	0.9	0.4
Total Current Assets	510.3	405.3	559.5	567.6	302.3	92.8	41.8
PP&E	97.9	101.1	13.3	11.9	10.8	22.1	2.2
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	362.2	61.4	152.3	125.2	162.5	1.8	0.2
Other Long Term Assets	7.7	7.9	(122.0)	(98.8)	11.5	0	0
Other Assets	0	0	0	0	0	0	0
Total Assets	978.0	575.8	603.1	605.9	487.2	116.7	44.2
LIABILITIES
Accounts Payable	6.0	7.1	4.3	4.0	4.4	3.3	2.1
Short Term Debt	13.1	6.3	7.9	7.2	6.5	3.4	0.3
Other Current Liabilities	35.1	34.4	23.9	19.6	7.2	4.6	2.3
Total Current Liabilities	67.8	85.7	63.3	101.0	110.6	34.6	4.7
Long Term Debt	0	78.3	26.8	28.7	29.5	17.8	0.4
Deferred Tax Income	0	0	0	(53.7)	0	0	0
Other Liabilities	0	0	(13.1)	(14.3)	(14.6)	109.1	73.6
Total Liabilities	142.4	180.8	113.0	146.3	203.3	191.1	78.7
EQUITY
Common Stock	7 K	6 K	6 K	5 K	4 K	0	0
Retained Earnings	(754.6)	(530.8)	(383.8)	(229.0)	(128.8)	(76.5)	(35.2)
Other Accumulative Comprehensive Income/Loss	(1.5)	(0.6)	(4.9)	(0.7)	(0.1)	6 K	0
Total Equity	835.6	395.0	490.2	459.6	283.9	(74.4)	(34.4)
Total Liabilities and Equity	978.0	575.8	603.1	605.9	487.2	116.7	44.2
SHARES OUTSTANDING
Common Shares Outstanding	75.0	58.4	53.9	48.0	17.3	44.5	44.5

Free